![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
200M COVID Jab Left Over Doses Leads SII Halting Production
As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in...
Recipharm secures vaccine manufacturing deal
Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top...
4 Trends Transforming the Never-Normal Future of Manufacturing
2021 Manufacturing Trends
If 2020 was the year of disruption, 2021 is the year of adaptation....
CapsCanada Launches Liquid-Filled Hard Capsule Manufacturing Service in North America
CapsCanada, a Lyfe Group company and leader in capsule technology for over three decades, is...
PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing...
PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the...
Altimmune Expands AdCOVID Manufacturing Collaboration with Lonza
Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has expanded its previously-announced AdCOVID™ manufacturing...
Jubilant HollisterStier Signs Manufacturing Agreement with Eli Lilly for COVID-19 Therapeutic Bamlanivimab
Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, recently announced that...
Recipharm signs manufacturing agreement with Enzymatica
Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science...
Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch...
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell...
T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse...